Girisopam
![]()  | |
| Clinical data | |
|---|---|
| ATC code | none | 
| Identifiers | |
  | |
| CAS Number | 
82230-53-3  | 
| PubChem (CID) | 71257 | 
| ChemSpider | 
64387  | 
| UNII | 
2LP301A921  | 
| ChEMBL | 
CHEMBL1915065  | 
| Chemical and physical data | |
| Formula | C18H17ClN2O2 | 
| Molar mass | 328.79 | 
| 3D model (Jmol) | Interactive image | 
  | |
  | |
|   | |
Girisopam[1] (GYKI-51189) is a drug which is a 2,3-benzodiazepine derivative, related to tofisopam[2] and zometapine. It has selective anxiolytic action with no sedative, anticonvulsant or muscle relaxant effects.[3][4][5]
See also
References
- ↑ US Patent 4322346
 - ↑ Psychotropics.dk
 - ↑ Andrási F, Horváth K, Sineger E, Berzsenyi P, Borsy J, Kenessey A, Tarr M, Láng T, Kórösi J, Hámori T. Neuropharmacology of a new psychotropic 2,3-benzodiazepine. Arzneimittelforschung. 1987 Oct;37(10):1119-24.
 - ↑ Horváth K, Andrási F, Botka P, Hámori T. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone. Acta Physiologica Hungarica. 1992;79(2):153-61.
 - ↑ Horváth EJ, Salamon C, Bakonyi A, Fekete MI, Palkovits M. [(3)H]-girisopam, a novel selective benzodiazepine for the 2, 3-benzodiazepine binding site. Brain Research. Brain Research Protocols. 1999 Jul;4(2):230-5.
 
This article is issued from Wikipedia - version of the 8/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
